Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| PFE | Pfizer Inc. | -0.48% | 43.72 | 0.9% | $906.73m | |
| JNJ | Johnson & Johnson | 1.96% | 136.57 | 0.6% | $870.01m | |
| MRK | Merck & Co., Inc. | -0.41% | 70.93 | 0.6% | $589.74m | |
| LLY | Eli Lilly and Company | 0.37% | 111.03 | 1.0% | $519.32m | |
| ABBV | AbbVie, Inc. | 3.05% | 91.90 | 2.2% | $500.29m | |
| BMY | Bristol-Myers Squibb Company | 0.33% | 57.80 | 1.4% | $347.60m | |
| NVS | Novartis AG Sponsored ADR | -1.17% | 84.76 | 0.2% | $178.01m | |
| AZN | AstraZeneca PLC Sponsored ADR | 0.15% | 39.14 | 1.3% | $152.53m | |
| GSK | GlaxoSmithKline plc Sponsored ADR | -0.75% | 39.50 | 0.2% | $88.09m | |
| NVO | Novo Nordisk A/S Sponsored ADR Class B | -0.74% | 43.06 | 0.1% | $86.57m | |
| SNY | Sanofi Sponsored ADR | -0.11% | 44.29 | 0.2% | $59.05m | |
| LCI | Lannett Company, Inc. | 2.17% | 4.25 | 37.0% | $7.26m | |
| AKTX | Akari Therapeutics Plc Sponsored ADR | -1.12% | 1.76 | 1.7% | $0.15m |
Company Profile
GenVec, Inc. is a clinical-stage gene delivery company, which engages in the development of therapeutics and vaccines. The firm designs, tests, and manufactures adenoviral-based product candidates using its proprietary AdenoVerse platform. Its products include CGF166-Hearing Loss; GV2311-RSV Vaccine; and GV2207-HSV-2 Immunotherapeutic. The company was founded in December 1992 and is headquartered in Gaithersburg, MD.